The Greek executive sold more than 130,000 shares the day the company announced the effectiveness of its vaccine
The CEO of Pfizer, Albert Bourla, earned 5.4 million dollars, about 4.4 million euros, after selling 62% of its shares this Monday, when the pharmaceutical company announced that the effectiveness of its vaccine exceeds 90%.
According to documents sent to US stock regulators and collected by Bloomberg, Bourla sold 130,686 shares when they were at $ 41.94 per share.
The executive took advantage of the company’s announcement, prior to the start of the session on Monday, to sell more than half of its share package. In this way Bourla, who has been with the company for 25 years, is left with a position of 81,812 shares.
The price of Pfizer shares has moderated since the beginning of the week. Last Monday, the price soared more than 6% and since then has dragged the main indices of the world before the forecasts of the distribution of the vaccine for next year.
1.3 billion doses of Pfizer vaccines.
- This Wednesday, the European Commission gave the green light to the purchase of 300 million doses between 2020 and the first quarter of 2021
- Pfizer expects to produce, together with Germany’s BioNTech, 1.3 billion vaccines by next year
- Spain will receive 10 million doses as advanced by the Minister of Health, Salvador Illa